Home Cart 0 Sign in  

[ CAS No. 2791-84-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 2791-84-6
Chemical Structure| 2791-84-6
Structure of 2791-84-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2791-84-6 ]

Related Doc. of [ 2791-84-6 ]

Alternatived Products of [ 2791-84-6 ]

Product Details of [ 2791-84-6 ]

CAS No. :2791-84-6 MDL No. :MFCD00038980
Formula : C26H29NO7S Boiling Point : -
Linear Structure Formula :- InChI Key :HVZUAIVKRYGQRM-LMOVPXPDSA-N
M.W : 499.58 Pubchem ID :13233366
Synonyms :

Calculated chemistry of [ 2791-84-6 ]

Physicochemical Properties

Num. heavy atoms : 35
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.23
Num. rotatable bonds : 11
Num. H-bond acceptors : 8.0
Num. H-bond donors : 2.0
Molar Refractivity : 131.28
TPSA : 141.37 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.52 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.36
Log Po/w (XLOGP3) : 1.16
Log Po/w (WLOGP) : 4.6
Log Po/w (MLOGP) : 3.17
Log Po/w (SILICOS-IT) : 3.25
Consensus Log Po/w : 3.11

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 2.0
Egan : 1.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.32
Solubility : 0.238 mg/ml ; 0.000476 mol/l
Class : Soluble
Log S (Ali) : -3.72
Solubility : 0.0944 mg/ml ; 0.000189 mol/l
Class : Soluble
Log S (SILICOS-IT) : -5.58
Solubility : 0.00133 mg/ml ; 0.00000265 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.96

Safety of [ 2791-84-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2791-84-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2791-84-6 ]
  • Downstream synthetic route of [ 2791-84-6 ]

[ 2791-84-6 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 2791-84-6 ]
  • [ 3397-65-7 ]
Reference: [1] Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1988, vol. 27, # 1-12, p. 405 - 408
  • 2
  • [ 2791-84-6 ]
  • [ 24277-39-2 ]
Reference: [1] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 8, p. 855 - 866
  • 3
  • [ 56-86-0 ]
  • [ 104-15-4 ]
  • [ 100-51-6 ]
  • [ 2791-84-6 ]
YieldReaction ConditionsOperation in experiment
61 g Inert atmosphere 10135] 29.4 g (0.2 mol) L-(+)-glutamic acid, 40 g (0.23 mol) p-toluenesulfonic acid, and 80 mE benzyl alcohol were dissolved in 500 mE methylbenzene. 11 mE water was separated out by backflow under the protection of nitrogen gas. The backflow was continued for 3 h, and 150 mE liquid was evaporated and removed. The solution was cooled down to 50° C., and then the reaction solution was poured into a beaker containing 600 mE petroleum ether for stirring 1 h. The precipitation was collected by filtration. The filter cake was dissolved in 280 mE of 95percent ethanol by heating, then the heating was stopped and the solution was cooled overnight. The precipitation was collected by filtration and dried in vacuum to produce 61 g E-(+)-glutamic acid dibenzyl ester p-toluenesulfonate (compound 1).
Reference: [1] European Journal of Medicinal Chemistry, 2008, vol. 43, # 12, p. 2699 - 2716
[2] Journal of Chemical Research, 2013, vol. 37, # 3, p. 177 - 180
[3] Journal of Chemical Research, 2013, vol. 37, # 3, p. 181 - 185
[4] Journal of the Chemical Society - Perkin Transactions 1, 1999, # 8, p. 855 - 866
[5] Patent: US2015/359900, 2015, A1, . Location in patent: Paragraph 0134; 0135
  • 4
  • [ 56-86-0 ]
  • [ 100-51-6 ]
  • [ 2791-84-6 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1991, vol. 25, # 4, p. 246 - 248[2] Khimiko-Farmatsevticheskii Zhurnal, 1991, vol. 25, # 4, p. 24 - 26
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2791-84-6 ]

Amino Acid Derivatives

Chemical Structure| 17664-93-6

[ 17664-93-6 ]

H-D-Leu-OBzl.TosOH

Similarity: 0.99

Chemical Structure| 17662-84-9

[ 17662-84-9 ]

H-D-Val-Obzl.TosOH

Similarity: 0.96

Chemical Structure| 16652-76-9

[ 16652-76-9 ]

H-Val-Obzl.TosOH

Similarity: 0.96

Chemical Structure| 2886-33-1

[ 2886-33-1 ]

H-Asp(OBzl)-Obzl.TosOH

Similarity: 0.95

Chemical Structure| 41036-32-2

[ 41036-32-2 ]

H-D-Ala-OBzl.TosOH

Similarity: 0.94